ShareValue scores for ALIMP.PA: Valuation 54, Quality 28, Growth 61, Health 51.

ALIMP.PA
Euronext Paris

Implanet SA

€0.17(+1.18%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 18%
Valuation
54
Fair Value
Price vs Value
Quality
28
Weak
Business Strength
Growth
61
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
42
Neutral
Price Trend

Company Details

About

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides an ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The company exports its products. Implanet S.A. was founded in 2006 and is headquartered in Martillac, France.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026